Literature DB >> 6991642

Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence.

M McCarthy, B Jubelt, D B Fay, R T Johnson.   

Abstract

The growth and cytopathogenicity of five strains of mumps virus were examined in six types of cell cultures and in neonatal hamsters. These strains included the MJ and RW strains, both recent cerebrospinal fluid isolates: the neuroadapted Kilham strain; the Enders strain adapted to chick embryo; and the Jeryl Lynn vaccine strain adapted to chick cell culture. The MJ, RW, and Kilham strains all produced infectious virus without restriction in vitro, but the RW strain did not cause obvious cytopathic effect; the MJ and Kilham strains were cytopathic. The Enders and Jeryl Lynn strains adapted to chick embryo cells were cytopathic and productive in chick cell culture but were restricted in ability to grow productively in vitro on mammalian cell types, even failing to produce noninfectious particles in some cases. In vitro cytopathogenicity was a host-independent property of a specific virus strain, but the type of cytopathic effect manifest in culture (eg, fusion, cytoplasmic vacuoles) depended on both the strain and the host cell. The ability of a virus strain to invade the brain parenchyma and infect neurons in vivo appeared to correlate with the strain's cytopathogenicity and not with passage history or adaptive status.

Entities:  

Mesh:

Year:  1980        PMID: 6991642     DOI: 10.1002/jmv.1890050102

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Complete nucleotide sequence of a mumps virus genotype I strain isolated in Korea.

Authors:  Joo-Yeon Lee; Byoung-Kuk Na; Ho-Dong Lee; Sung-Wook Chang; Kyung-Ae Kim; Jee-Hee Kim; Hae-Wol Cho; Joon Kim; Chun Kang
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

2.  Function of small hydrophobic proteins of paramyxovirus.

Authors:  Rebecca L Wilson; Sandra M Fuentes; Ping Wang; Erica C Taddeo; Alicia Klatt; Andrew J Henderson; Biao He
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.

Authors:  A Löve; R Rydbeck; K Kristensson; C Orvell; E Norrby
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses.

Authors:  Y Hosaka; Y Yasuda; O Seriburi; M G Moran; K Fukai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis.

Authors:  A Löve; R Rydbeck; G Utter; C Orvell; K Kristensson; E Norrby
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.

Authors:  J S Wolinsky; M N Waxham; A C Server
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Identification of an amino acid that defines the fusogenicity of mumps virus.

Authors:  K Tanabayashi; K Takeuchi; K Okazaki; M Hishiyama; A Yamada
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.

Authors:  F Gonzalez-Scarano; R S Janssen; J A Najjar; N Pobjecky; N Nathanson
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

9.  Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate.

Authors:  Pei Xu; Zhixiang Huang; Xiudan Gao; Frank J Michel; Gwen Hirsch; Robert J Hogan; Kaori Sakamoto; Wenzhe Ho; Jianguo Wu; Biao He
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist.

Authors:  D F Young; M C Galiano; K Lemon; Y-H Chen; J Andrejeva; W P Duprex; B K Rima; R E Randall
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.